---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-047741"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:35:01.179314+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics raises ~$5M in registered direct offering and private placement at $0.31/unit

## Summary
- Offering of 16,129,033 shares of common stock and accompanying Common Warrants at $0.31 per unit.
- Gross proceeds approximately $5.0 million; net proceeds for working capital and general corporate purposes.
- Common Warrants exercisable at $0.31 per share, subject to stockholder approval and increase in authorized shares.
- Concurrent warrant amendment reduces exercise price of 2,142,854 existing warrants from $2.26 to $0.31.
- H.C. Wainwright acted as placement agent with 7.0% cash fee and warrants for 1,129,032 shares.

## SEC filing metadata
- accession: 0001104659-26-047741
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926047741/0001104659-26-047741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926047741/tm2612578d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-047741
- JSON: https://secwatch.observer/filing/0001104659-26-047741.json
- Plain text: https://secwatch.observer/filing/0001104659-26-047741.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.